To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat <font color="red">patients_6</font> <font color="red">with_6</font> <font color="red">primary_7</font> <font color="red">Raynaud_7</font> <font color="red">'s_7</font> <font color="red">phenomenon_7</font> <font color="red">in_7</font> <font color="red">South_7</font> <font color="red">Korea_7</font> <font color="red">;_7</font> <font color="red">Korean_4</font> <font color="red">Raynaud_4</font> <font color="red">study_3</font> <font color="red">(_3</font> <font color="red">KOARA_3</font> <font color="red">study_3</font> <font color="red">)_3</font> <font color="red">._3</font> <font color="red">
<br>
<br>_1</font> This study examined the efficacy and safety of nifedipine sustained release ( nifedipine SR ) compared with Ginkgo biloba extract as treatment for <font color="red">primary_1</font> <font color="red">Raynaud_1</font> <font color="red">'s_1</font> <font color="red">phenomenon_1</font> <font color="red">(_1</font> <font color="red">RP_1</font> <font color="red">)_1</font> in Korea . <font color="red">Primary_1</font> <font color="red">RP_1</font> <font color="red">were_1</font> <font color="red">screened_1</font> <font color="red">and_1</font> <font color="red">assigned_1</font> <font color="red">to_1</font> <font color="red">either_1</font> <font color="red">the_1</font> <font color="red">nifedipine_2</font> <font color="red">SR_2</font> <font color="red">group_2</font> <font color="red">(_2</font> <font color="red">Group_2</font> <font color="red">N_2</font> <font color="red">)_2</font> <font color="red">or_2</font> <font color="red">the_2</font> <font color="red">Ginkgo_2</font> <font color="red">biloba_2</font> <font color="red">extract_2</font> <font color="red">group_2</font> <font color="red">(_2</font> <font color="red">Group_2</font> <font color="red">G_2</font> <font color="red">)_2</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">ratio_1</font> <font color="red">of_1</font> <font color="red">2:1_1</font> <font color="red">._1</font> After a run - in period of 2 weeks , patients received treatment for 8 weeks . We observed the percent improvement of the RP attack rate between before and after the 8-week treatment . <font color="red">Ninety_6</font> <font color="red">-_6</font> <font color="red">three_6</font> <font color="red">subjects_6</font> <font color="red">were_3</font> <font color="red">randomly_3</font> <font color="red">assigned_3</font> <font color="red">._3</font> The percent improvement in <font color="red">Group_1</font> <font color="red">N_1</font> was 50.1% at 8 weeks after treatment , while it was 31.0% in <font color="red">Group_1</font> <font color="red">G_1</font> ( p = 0.03 ) . No serious adverse events occurred , and almost adverse events were mild and improved without specific treatment . nifedipine SR was more effective than Ginkgo biloba extract for treatment of primary RP in <font color="red">Korean_2</font> <font color="red">patients_2</font> <font color="red">._2</font> Both drugs were tolerable with <font color="red">primary_1</font> <font color="red">RP_2</font> <font color="red">patients_2</font> <font color="red">._2</font>